20/15 Visioneers reported that Mimrylo (rusfertide) cleared August 28 as the first hepcidin-mimetic for polycythemia vera.

Public source

Publisher name

Public post

🧬 Science & Technology Weekly: Four FDA Firsts in Four Days, and a 135-Day Review The FDA announced a first-in-class or first-indication clearance on four consecutive w…

Log in to read the full post

Company

20/15 Visioneers

Better Vision=Better Outcomes Bringing the holistic approach to Science with Culture/Data/Process/Technology

Industry
Information Technology & Services
Location
HEREFORD, US
Company size
11–50 employees

About 20/15 Visioneers

20/15 Visioneers was founded on the principle of providing the best possible value in scientific informatics. We believe there is a cadence to doing this right and have many case studies to prove our effectiveness. Before investing millions of dollars in software, hardware, and possibly inefficient work practices you might want to listen to what we have to say. Hands-on experience (actual work and strategy) with not only R&D but also scientific data foundations, imaging, predictive (suggestive) science and much-needed change management. Currently helping clients with their R&D digitization, electronic laboratory environments and clinical research informatics needs. We serve biotech, biopharma, materials, chemicals, oil and gas, food and consumer packaged goods. We can help you in important roles on an interim basis by getting structure in place and the proper logistics to hire and scale the organization.

See more

Latest activity

12 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.